Temporal arteritis medical therapy

Revision as of 20:24, 29 August 2012 by Michael Maddaleni (talk | contribs) (Created page with "__NOTOC__ {{Temporal arteritis}} {{CMG}} ==Overview== ==Medical Therapy== ==Pharmacotherapy== ===Acute Pharmacotherapies=== Corticosteroids must be started as soon a...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Temporal Arteritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Temporal Arteritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Temporal arteritis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Temporal arteritis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Temporal arteritis medical therapy

CDC on Temporal arteritis medical therapy

Temporal arteritis medical therapy in the news

Blogs on Temporal arteritis medical therapy

Directions to Hospitals Treating Temporal arteritis

Risk calculators and risk factors for Temporal arteritis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

Pharmacotherapy

Acute Pharmacotherapies

Corticosteroids must be started as soon as the diagnosis is suspected (even before the diagnosis is confirmed by biopsy). Steroids do not prevent the diagnosis later being confirmed by biopsy, although certain changes in the histology may be observed towards the end of the first week of treatment and are more difficult to identify after a couple of months.[1]

A 3 day course of pulse steroids with 250 mg of IV solumedrol BID is critical in reducing the risk of permanent visual loss. If there is progression of visual loss on steroids, IV heparin can be administered to reduce the risk of thrombotic occlusion.

Treatment should not be deferred while waiting on the results of a temporal artery biopsy.

References

  1. Font RL, Prabhakaran VC (2007). "Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases". The British journal of ophthalmology. 91 (2): 204–9. doi:10.1136/bjo.2006.101725. PMID 16987903.